Skip to main content
European Health and Digital Executive Agency (HaDEA)
Article d’actualité24 mars 2022Agence exécutive européenne pour la santé et le numérique

Supporting the European Health Emergency Preparedness and Response Authority (HERA) - two new contracts signed

HERA HADEA

Antimicrobial resistance (AMR) is a global concern and continues to be a significant cross-border health threat. AMR is responsible for an estimated 33,000 deaths per year in the EU and estimated to cost the EU €1.5 billion per year in healthcare costs and productivity losses[1]. The spread of new resistances, due to enhanced international travel, runs the risk of creating similar scenarios to that of COVID-19.

Background

The European Commission is building a strong European Health Union. In order to achieve this goal, protection, prevention, preparedness and response against human health hazards is a top priority.

To this end, the Commission launched a new European Health Emergency Preparedness and Response Authority (HERA) for health emergencies, to develop, produce and procure medical countermeasures before and during a health crisis.

HERA aims to:

  • Improve EU health security coordination before and during crises;
  • Bring together the EU Member States, industry and relevant stakeholders;
  • Develop, produce, procure, stockpile and equitably distribute medical countermeasures;
  • Reinforce the global health emergency response architecture.

Relevant links

HERA overview page

HERA press release

EU Health Priorities

 

[1] EU Action on Antimicrobial Resistance, https://ec.europa.eu/health/antimicrobial-resistance/eu-action-antimicr….

Détails

Programme Sector
Health
Programme
EU4Health
Tags
EU financingHealthUnionPublic health